Look Who's Talking… About Liquid Biopsy Technology

I've told this story before, but it bears repeating here...

Back in April 2015, about a month after I originally recommended "Liquid Biopsy" stock TrovaGene Inc. (Nasdaq: TROV), biotech-sector executive Tina Nova wrote in a Wired magazine essay that the still-in-development cancer-screening technology is "the most exciting thing I've seen since I started my career."

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK